ArticleScientific reports2026
Cardioprotective effects of curcumin and piperine against obesity induced oxidative stress in rats.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the adverse effects of obesity is cardiovascular disease (CVD). This study aimed to estimate the preventive effect of curcumin (CUR) (100 mg/kg body w.) and piperine (PIP) (5 mg/kg body weight) orally treated for 8 weeks in obese rats against CVD. When rats were fed a high-fat diet (HFD), high-density lipoprotein cholesterol (HDL-C), serum total cholesterol (TC), triglyceride (TG), Castellis risk index, CKD-II, atherogenic index (AC), and serum insulin increased. Results showed decreased levels of antioxidants catalase (CAT), glutathione peroxidase (Gpx), and superoxide dismutase (SOD), and increased levels of oxidative stress, including malondialdehyde (MDA), nitric oxide (NO), and reactive oxygen species (ROS), in the hearts of HFD rats. Other changes included a significant decrease in the activity of cardiac Na+/K+ ATPase, as well as increases in cardiac inflammatory markers, including TNF-α, IL-1, and IL-6. This was accompanied by further increases in serum C-reactive protein (CRP), monocyte chemotactic protein 1 (MCP1), and plasminogen activator inhibitor 1 (PAI1), as well as decreases in adiponectin levels. Furthermore, serum troponin T, creatine kinase-MB (CK-MB), and myoglobin levels were increased and downregulating NF-κB gene expression. Histological examination revealed multiple changes in the hearts of obese rats. CUR + PIP intake suppressed obesity-induced cardiac oxidative stress, inflammation, and histological damage. Thus, these results suggest that CUR + PIP intake may help in preventing obesity-related health risks and cardiac toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.